🔴 Indaptus Therapeutics is trading 5.1% down today, reversing part of September 17 advance

Indaptus Therapeutics is trading 5.1% down at $3.73, with no fresh company-specific announcement clearly explaining the September 18 decline.

• The move reverses part of the September 17, 2026, 22.43% advance.
• The most recent identifiable catalyst was the September 8 private placement for approximately $24 million, reported before today’s move.
• Biotech-sector strength does not explain the negative direction, while broader indexes are modestly lower.